Prenetics Global Limited
PRE
Prenetics Global Limited Class A Ordinary Share is the common equity security of Prenetics Global Limited, a health sciences company focused on consumer health products and services. The company operates through brands and platforms that include IM8, which offers scientifically formulated supplements and longevity-focused nutrition products, Europa, which provides sports nutrition products, and CircleDNA, a direct-to-consumer DNA testing service. Prenetics Global Limited serves consumers seeking wellness, nutrition, and genetic insights, with its products distributed across multiple markets in the United States, Hong Kong, and other international regions. The Class A Ordinary Share represents an ownership interest in the company’s current health and wellness business segments and reflects its role in the broader consumer health sciences market.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$143M
▲ +201.7% YoY
Net Income (TTM)
-$48M
▲ +19.7% YoY
Op. Margin
-36.00%
▲ +124.9pp YoY
ROIC
-17.97%
▲ +2.7pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$76M
▼ -155.1% YoY
Op. Cash Flow (FY)
-$22M
▲ +24.7% YoY
Net Debt
-$62M
Net Cash Position
Cash & Equiv.
$63M
3Y CAGR: +91.5%
Continue Research
Peers
Packaged Foods · Pick stocks to compare with PRE
Held by ETFs
PRE is in 1 US ETF. The largest of them, with PRE's weight in each:
Prenetics Global (PRE) in four numbers
Questions about Prenetics Global
Is Prenetics Global (PRE) overvalued?
At $8.80, Prenetics Global's price is 81% below the $45.68 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Prenetics Global's fair value?
Intrinsiqq's calculator puts Prenetics Global's fair value at $45.68 a share. It grows revenue per share 30% a year for 5 years, applies an exit P/S of 2.4, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $34.26. Every input can be changed on the Intrinsic Value tab.
Is Prenetics Global a high-quality business?
Prenetics Global scores 40 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 6 checks computed from company filings. Its best check is revenue growth at 81.4%, and its weakest is return on capital at -18.0%. The Quality tab shows every check against its target.
Does Prenetics Global (PRE) pay a dividend?
No. Prenetics Global (PRE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PRE
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.